• 16% increase in revenue to $33.8 million
• 22.2% decrease in net loss to $6.2 million
• Positive operating cash flow of $0.9 million

Mach7 Technologies Limited, a leading provider of medical imaging software, has reported its preliminary final results for the financial year ended 30 June 2025. The company delivered a solid performance, with revenue increasing by 16% to $33.8 million, compared to $29.1 million in the previous year. The net loss for the year decreased by 22.2% to $6.2 million, down from $8.0 million in the prior year. Mach7 also reported positive operating cash flow of $0.9 million, a significant achievement as the company transitions to a predominantly subscription sales model. The company's recurring revenue, which includes subscription and maintenance and support revenue, accounted for 75% of total revenue and represented 80% of operating expenditure, providing a strong foundation for future growth. Mach7 continued to focus on disciplined cost management, with operating expenditure increasing by 9% compared to the prior year. The company's financial position remains solid, with $23.1 million in cash on hand and no debt as of 30 June 2025.

Mach7 remains focused on building market share in enterprise imaging across its core regions of North America, Asia Pacific, and the Middle East. The company is undertaking a review of its market positioning and executing a shift to a customer-value centric growth strategy.